A Short-Duration Gonadotropin-Releasing Hormone Stimulation Test for the Diagnosis of Central Precocious Puberty

被引:2
|
作者
Pellegrin, Maria Chiara [1 ]
Marzin, Chiara [2 ]
Monasta, Lorenzo [1 ]
Tamaro, Gianluca [1 ]
Vidonis, Viviana [1 ]
Vittori, Giada [1 ]
Faleschini, Elena [1 ]
Barbi, Egidio [1 ,2 ]
Tornese, Gianluca [1 ,2 ]
机构
[1] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, I-34129 Trieste, Italy
[2] Univ Trieste, Dept Med Surg & Hlth Sci, I-34129 Trieste, Italy
来源
MEDICINA-LITHUANIA | 2024年 / 60卷 / 01期
关键词
precocious puberty; GnRH stimulation test; LHRH stimulation test; LUTEINIZING-HORMONE; WEIGHT; HEIGHT; UPDATE; SAMPLE;
D O I
10.3390/medicina60010024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: The gonadotropin-releasing hormone (GnRH) stimulation test is the gold standard method for diagnosing central precocious puberty (CPP), although it requires multiple blood samplings over 120 min. This study aimed to evaluate if a shorter test may have an equivalent diagnostic accuracy. Materials and Methods: We retrospectively reviewed the GnRH tests of 188 consecutive pediatric patients (169 females) referred for signs of early pubertal development. The diagnostic accuracy of the hormonal levels was evaluated at different time points (15, 0, 60, 90, and 120 min after the GnRH stimulus). Results: A diagnosis of CPP was made in 130 cases (69%), with 111 (85%) being female. Sensitivity and specificity ratings higher than 99% for the diagnosis of CPP were achieved for LH levels >= 4.7 mU/mL at 30 and 60 min after the stimulus (area under the ROC curve (AUC) = 1), with no further increase in the diagnostic accuracy in the remaining time points. No sex differences in diagnostic accuracy were found. The LH/FSH ratio at 30 min showed a sensitivity of 94.9%, with an AUC of 0.997 and a value >= 0.76. Conclusions: A short-duration GnRH test of 60 min provided optimal results for the diagnosis of CPP. Extending the test for an extra hour is therefore unnecessary and inadvisable.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls
    Shi, Yuzhen
    Ma, Ziyi
    Yang, Xi
    Ying, Yanqin
    Luo, Xiaoping
    Hou, Ling
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [22] Changes in body mass index during gonadotropin-releasing hormone agonist treatment for central precocious puberty and early puberty
    Hae Sang Lee
    Jong Seo Yoon
    Jung Ki Roh
    Jin Soon Hwang
    Endocrine, 2016, 54 : 497 - 503
  • [23] Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: Final height results
    Mul, D
    Bertelloni, S
    Carel, JC
    Saggese, G
    Chaussain, JL
    Oostdijk, W
    HORMONE RESEARCH, 2002, 58 (01) : 1 - 7
  • [24] Central precocious puberty: consider early treatment with gonadotropin-releasing hormone analogues to preserve maximum height
    Medical Writers A.
    Drugs & Therapy Perspectives, 2015, 31 (10) : 341 - 344
  • [25] The effects of a gonadotropin-releasing hormone analogue combined with a healthy lifestyle on girls with idiopathic central precocious puberty
    Fang, Lei
    Zhou, Huanrong
    Chen, Hua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (07): : 5181 - 5186
  • [26] Factors to Predict Positive Results of Gonadotropin Releasing Hormone Stimulation Test in Girls with Suspected Precocious Puberty
    Nam, Hyo-Kyoung
    Rhie, Young Jun
    Son, Chang Sung
    Park, Sang Hee
    Lee, Kee-Hyoung
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (02) : 194 - 199
  • [27] The effect of gonadotropin-releasing hormone analog treatment (leuprolide) on body fat distribution in idiopathic central precocious puberty
    Tascilar, Mehmet Emre
    Bilir, Pelin
    Akinci, Aysehan
    Kose, Kenan
    Akcora, Dilek
    Inceoglu, Deniz
    Fitoz, Suat Omer
    TURKISH JOURNAL OF PEDIATRICS, 2011, 53 (01) : 27 - 33
  • [28] Central precocious puberty: A single blood sample after gonadotropin-releasing hormone agonist administration in monitoring treatment
    Salerno, M
    Di Maio, S
    Gasparini, N
    Mariano, A
    Macchia, V
    Tenore, A
    HORMONE RESEARCH, 1998, 50 (04) : 205 - 211
  • [29] Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious puberty
    Cho, Ah Young
    Ko, Su Yeong
    Lee, Jae Hee
    Kim, Eun Young
    ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2021, 26 (04) : 259 - 265
  • [30] Timing for discontinuation of treatment with a long-acting gonadotropin-releasing hormone analog in girls with central precocious puberty
    Ohyama, K
    Tanaka, T
    Tachibana, K
    Niimi, H
    Fujieda, K
    Matsuo, N
    Satoh, M
    Hibi, I
    ENDOCRINE JOURNAL, 1998, 45 (03) : 351 - 356